Therapy Areas: Allergy
15 January 2018 - WuXi Biologics (WuXi Bio, 02269.HK), a global open-access biologics technology platform company, offering end-to-end solutions for biologics discovery, development and manufacturing,...
15 January 2018 - United States-based provider of a range of pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology sectors, Charles River Laboratories ...
12 January 2018 - United Kingdom-based Allergy Therapeutics has completed recruitment of patients in the PQ Birch phase III clinical trial, it was reported yesterday.The PQBirch301 study is a pivotal ...
11 January 2018 - - Cambridge, UK-based drug discovery company Storm Therapeutics has raised an additional GBP4 m of funding from Taiho Ventures, LLC, the strategic corporate venture capital arm of Ta...
9 January 2018 - STS Medical Ltd revealed on Monday the receipt of regulatory clearance from the US Food and Drug Administration (FDA) for its composite sinus stent for the treatment of chronic sinusi...
8 January 2018 - - The FDA has granted US-based next-generation antibiotics developer VenatoRx Pharmaceuticals, Inc.'s lead antibiotic program, VNRX-5133, an injectable broad-spectrum β-lact...